MR Guidance for Liver and Pancreas

What this study is about

This is a single centre, single arm, prospective feasibility study that aims to see whether magnetic resonance imaging (MRI) as a source of image guidance before each radiation treatment fraction is feasible, and also if it may provide information that could potentially be used during the treatment to improve the radiation treatment plan. Patients will have 5 MRIs with each of their RT sessions. If patients' RT treatment will consist of more than 5 fractions, only 5 MRIs will be done with any 5 RT fractions. Patients will be completing a short questionnaire at the end of each MRI. A patient questionnaire will also be completed at the end of the study to assess for patient satisfaction. There will be 30 evaluable patients enrolled to the study.

Who can join (things the study team will check)

✅ You may be able to join if…

• Patients 18 years or older
• Diagnosed with locally advanced pancreatic cancer or hepatocellular carcinoma being considered for treatment with chemoradiation, long course RT, or SBRT with curative intent or palliative intent, planned for 5 or more RT fractions

🚫 You may not be able to join if…

• Contraindications for MRI: ferromagnetic prosthesis, pacemaker / implanted defibrillator, claustrophobia

Where this trial is running

• University Health Network - Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Who to contact

Edel Sexton · 416-946-4501 · Edel.Sexton@uhn.ca

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT03582189.